Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The Efficacy Comparison Between Mirabegron and Antimuscarinics in Treating Overactive Bladder: a Systematic Review and Meta-Analysis

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-E-007-Monday
  • By: CHEN, Hsiao Ling (Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung,Taiwan, Pharmacy, Kaohsiung City, China Taiwan)
  • Co-author(s): Hsiao Ling Chen: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Tun-Cheh Chen: Division of Infectious Diseases, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Hsiang Ying Lee: Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Wei-Hsuan Huang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Hung-Fang Pan: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Chiou-Mei Wu: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Ya-Ling Wang: Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan, Province of China
    Hsiu-Mei Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Yong-Chieh Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  • Abstract:

    Backgrounds

    Antimuscarinic drugs have been the first line choice of overactive bladder (OAB) treatment; however, side effects were clearly a major reason for noncompliance. Mirabegron, a β3-adrenoceptor agonist, was investigated to be effective and safe for OAB.

    Aims

    To perform a meta-analysis on the efficacy comparison between antimuscarinics and

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses